SOCS-1 protein prevents Janus Kinase/STAT-dependent inhibition of beta cell insulin gene transcription and secretion in response to interferon-gamma

The Journal of Biological Chemistry
Sandra CottetBernard Thorens

Abstract

In the pathogenesis of type I diabetes mellitus, activated leukocytes infiltrate pancreatic islets and induce beta cell dysfunction and destruction. Interferon (IFN)-gamma, tumor necrosis factor-alpha and interleukin (IL)-1 beta play important, although not completely defined, roles in these mechanisms. Here, using the highly differentiated beta Tc-Tet insulin-secreting cell line, we showed that IFN-gamma dose- and time-dependently suppressed insulin synthesis and glucose-stimulated secretion. As described previously IFN-gamma, in combination with IL-1 beta, also induces inducible NO synthase expression and apoptosis (Dupraz, P., Cottet, S., Hamburger, F., Dolci, W., Felley-Bosco, E., and Thorens, B. (2000) J. Biol. Chem. 275, 37672--37678). To assess the role of the Janus kinase/signal transducer and activator of transcription (STAT) pathway in IFN-gamma intracellular signaling, we stably overexpressed SOCS-1 (suppressor of cytokine signaling-1) in the beta cell line. We demonstrated that SOCS-1 suppressed cytokine-induced STAT-1 phosphorylation and increased cellular accumulation. This was accompanied by a suppression of the effect of IFN-gamma on: (i) reduction in insulin promoter-luciferase reporter gene transcription, (ii)...Continue Reading

References

Oct 1, 1982·Analytical Biochemistry·L C GreenS R Tannenbaum
May 1, 1994·The Journal of Clinical Investigation·D L EizirikC Hellerström
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·S EfratX Wang
May 26, 1995·Science·J D KatzD Mathis
Feb 3, 1997·The Journal of Experimental Medicine·M G von Herrath, M B Oldstone
Jun 26, 1997·Nature·R StarrD J Hilton
Sep 12, 1997·Science·J E Darnell
Nov 5, 1997·Nature Biotechnology·R ZuffereyD Trono
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·B WangD Mathis
Jul 29, 1998·Diabetes/metabolism Reviews·A Rabinovitch
Aug 27, 1998·Biochemical Pharmacology·A Rabinovitch, W L Suarez-Pinzon
Sep 17, 1998·The Journal of Clinical Investigation·H E ThomasT W Kay
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·R StarrW S Alexander
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·T NakaT Kishimoto
Feb 1, 2000·Trends in Endocrinology and Metabolism : TEM·T W KayJ Allison
Jun 3, 2000·Annual Review of Immunology·H YasukawaA Yoshimura

❮ Previous
Next ❯

Citations

Jul 13, 2002·Trends in Molecular Medicine·Shimon Efrat
Apr 27, 2011·The Journal of Experimental Medicine·Kenneth J OestreichAmy S Weinmann
Jun 27, 2002·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Shimon Efrat
Mar 11, 2005·European Journal of Endocrinology·Carmela SantangeloFrancesco Dotta
Sep 18, 2007·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Dan WeiWenjun Ding
May 13, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Juliet EmamaulleeJohn F Elliott
Oct 28, 2003·Diabetes·Malin Flodström-TullbergNora Sarvetnick
Jan 30, 2007·Diabetes·Sif G RønnThomas Mandrup-Poulsen
Jun 1, 2016·Frontiers in Immunology·Cheng Ye, John P Driver
Sep 21, 2007·Molecular and Cellular Endocrinology·Eun-Kyung KimByung-Hyun Park
Oct 1, 2003·The Journal of Pathology·Andrea TannapfelChristian Wittekind
Mar 7, 2014·European Journal of Immunology·Yan LiangDong-Qing Ye
Mar 29, 2002·Nature Immunology·Malin FlodströmNora Sarvetnick
May 17, 2008·Biochemical Society Transactions·Conny GysemansChantal Mathieu
Jun 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Monica FedericiCristina Albanesi
Jan 19, 2002·Annals of the New York Academy of Sciences·B ThorensS Cottet
Nov 17, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mark H WeninkTimothy R D J Radstake
Jan 22, 2013·Cell Biochemistry and Function·Dariusz SuchyBogusław Okopień
Jan 15, 2014·Molecular Biology Reports·Xiaotao FengQiuyan Jiang
Apr 18, 2006·Trends in Endocrinology and Metabolism : TEM·Jean-François JasminMichael P Lisanti
Nov 21, 2007·Advanced Drug Delivery Reviews·Shimon Efrat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis